Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array

Clinical and Vaccine Immunology

Volumn 16, Issue 1, 2009, Pages 122-126

  Lim, JaeHyun ^a   Derrick, Steven C ^a   Kolibab, Kristopher ^a   Yang, Amy Li ^a   Porcelli, Steven ^b   Jacobs, William R ^b   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; EARLY SECRETORY ANTIGENIC TARGET 6 ANTIGEN 85B FUSION PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYBRID PROTEIN; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 27; MYCOBACTERIUM VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SYNTHESIS; TUBERCULOSIS; UPREGULATION;

ANIMALS; CYTOKINES; GENE EXPRESSION PROFILING; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUBERCULOSIS VACCINES; VACCINES, DNA;

EID: 58149400796     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00359-08     Document Type: Article

References (29)

1. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Interleukin-17 in pulmonary host defense. Exp. Lung Res. 33:507-518.
2. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702.
3. Cole, A. M., T. Ganz, A. M. Liese, M. D. Burdick, L. Liu, and R. M. Strieter. 2001. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 167:623-627.
4. Delogu, G., A. Li, C. Repique, F. Collins, and S. L. Morris. 2002. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect. Immun. 70:292-302.
5. Derrick, S. C., A. L. Yang, and S. L. Morris. 2004. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23:780-788.
6. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
7. Flynn, J. L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinburgh) 84:93-101.
8. Fuller, C. L., J. L. Flynn, and T. A. Reinhart. 2003. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect. Immun. 71:7023-7034.
9. Goter-Robinson, C., S. C. Derrick, A. L. Yang, B. Y. Jeon, and S. L. Morris. 2006. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses. Vaccine 24:3522-3529.
10. Higgins, S. C., A. G. Janecki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177:7980-7989.
11. Hinchey, J., S. Lee, B. Y. Jeon, R. J. Basaraba, M. M. Venkataswamy, B. Chen, J. Chan, M. Braunstein, I. M. Orme, S. C. Derrick, S. L. Morris, W. R. Jacobs, Jr., and S. A. Porcelli. 2007. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Investig. 117:2279-2288.
12. Huang, D., L. Qiu, R. Wang, X. Lai, G. Du, P. Seghal, Y. Shen, L. Shao, L. Halliday, J. Fortman, L. Shen, N. L. Letvin, and Z. W. Chen. 2007. Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J. Infect. Dis. 195:55-69.
13. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5:521-531.
14. Khader, S. A., G. K. Bell, J. E. Pearl, J. J. Fountain, J. Rangel-Moreno, G. E. Gilley, F. Shen, S. M. Eaton, S. I. Gaffen, S. L. Swain, R. M. Locksley, L. Haynes, T. D. Randall, and A. M. Cooper. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377.
15. Korn, T., E. Bettelli, W. Gao, J. Awasthi, A. Jäger, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484-487.
16. Laan, M., Z. H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, D. C. Gruenert, B. E. Skough, and A. Linde. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162:2347-2352.
17. Leonard, W. J., and R. Spolski. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688-698.
18. Levine, A. J., and A. H. Brivanlou. 2006. GDF3 at the crossroads of TGFbeta signaling. Cell Cycle 5:1069-1073.
19. Linge, H. M., M. Collin, A. Giwercman, J. Milan, A. Bjartell, and A. Egesten. 2008. The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma. J. Interferon Cytokine Res. 28:191-196.
20. Mollenkopf, H. J., K. Hahnke, and S. H. E. Kaufmann. 2006. Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect. 8:136-144.
21. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today 19:491-494.
22. Pearl, J. E., S. A. Khader, A. Solache, L. Gilmartin, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2004. IL-27 signaling compromises control of bacterial growth in Mycobacteria-infected mice. J. Immunol. 173:7490- 7496.
23. Qiu, B., K. A. Frait, F. Reich, E. Komuniecki, and S. W. Chensue. 2001. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am. J. Pathol. 158:1503-1515.
24. Rhoades, E. R., A. M. Cooper, and I. M. Orme. 1995. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63:3871-3877.
25. Rodgers, A., K. M. Whitmore, and K. B. Walker. 2006. Potential correlates of BCG induced protection against tuberculosis detected in a mouse aerosol model using gene expression profiling. Tuberculosis 86:255-262.
26. Soares, A. P., T. J. Scriba, S. Joseph, R. Harbacheuski, R. A. Murray, S. J. Gelderbloem, A. Hawkridge, G. D. Hussey, H. Maecker, G. Kaplan, and W. A. Hanekom. 2008. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180:3569-3577.
27. van Pinxteren, L. A., J. P. Cassidy, B. H. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30:3689-3698.
28. World Health Organization. 2008. Global tuberculosis control - surveillance, planning, financing. World Health Organization, Geneva, Switzerland.
29. Young, D. B., M. D. Perkins, K. Duncan, and C. E. Barry III. 2008. Confronting the scientific obstacles to global control of tuberculosis. J. Clin. Investig. 118:1255-1265.